Sapience Therapeutics, Inc.
Records under this name other than the patents Sapience Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Back to Sapience Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,015,198 | Products and Compositions Held by another company In force · High confidence | In force | High confidence | |
| US 11,174,483 | Products and Compositions Held by another company In force · High confidence | In force | High confidence | |
| US 11,319,537 | Nucleic Acids for Inhibiting Expression of Lpa in a Cell Held by another company In force · High confidence | In force | High confidence | |
| US 12,054,717 | Nucleic Acids for Inhibiting Expression of Lpa in a Cell Held by another company In force · High confidence | In force | High confidence | |
| US 12,084,656 | Products and Compositions Held by another company In force · Low confidence | In force | Low confidence | |
| US 11,560,563 | siRNAs WITH VINYLPHOSPHONATE AT THE 5' END OF THE ANTISENSE STRAND Held by another company In force · High confidence | In force | High confidence | |
| US 11,499,153 | Nucleic Acids for Inhibiting Expression of Lpa in a Cell Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 11,873,489 | Nucleic Acids for Inhibiting Expression of a Target Gene Comprising Phosphorodithioate Linkages Held by another company In force · High confidence | In force | High confidence | |
| US 12,076,335 | Nucleic Acids for Inhibiting Expression of TMPRSS6 and Iron Chelators Held by another company In force · High confidence | In force | High confidence | |
| US 11,299,738 | Further novel oligonucleotide-ligand conjugates Lapsed on the fee record Ended Apr 12, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 12, 2026 | USPTO record |